Source-grounded facts extracted from My Size, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
My Size, Inc. reported first quarter ended March 31, 2026 results: revenue approximately $2.39 million, net income approximately $1.48 million.
“EX-99.1 (EX-99.1) --- MySize Reports 62% Revenue Growth in First Quarter 2026 as Integrated AI Fashion Platform Continues Expansion ● Revenue increased 62% year-over-year to $2.39 million ● Gross profit increased 124% year-over-year ● Gross margin improved to 39.3% ● Net loss increased 39% year-over-year ● Continued expansion of AI sizing, resale and”
My Size, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
“ule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain”
My Size, Inc. completed an acquisition involving Sellers (holders of 100% of share capital of ShoeSize.Me AG) for a cash payment of $150,000 and (ii) 241,093 shares of the Company’s common stock having an aggregate value of $290,000 (closed 2025-09-08).
“day (the “Closing Date”). In consideration for the purchase of the shares of Target and in accordance with the Purchase Agreement, the Sellers received (i) a cash payment of $150,000 and (ii) 241,093 shares of the Company’s common stock (the “Shares”) having an aggregate value of $290,000 (the “Equity Consideration”), determined by dividing $290,000 by the”
My Size, Inc. completed an acquisition involving Casi Nuevo Kids, S.L. for €610,806.81 (approximately $679,000) (closed 2025-05-09).
“chief marketing officer, who have transferred to New Percentil in connection with the Acquisition (the “Percentil Employees”). The total purchase price of the Acquisition was €610,806.81 (approximately $679,000), which consists of (i) €40,000 (approximately $44,500) paid by the Company’s wholly-owned subsidiary, Naiz Bespoke Technologies, S.L., (ii) €358,196”
Roy Golan was appointed as Audit Committee chair at My Size, Inc..
“Mr. Golan was additionally appointed to the Audit Committee as chair, the Compensation Committee, and Nominating and Corporate Governance Committee.”
Roy Golan was appointed as Class I director at My Size, Inc..
“on March 6, 2025, the Company’s board of directors appointed Roy Golan as a Class I director to replace Mr. Elmaliah, effective immediately.”
Oren Elmaliah departed as member of the board of directors at My Size, Inc..
“As a then member of the board of directors of the Company, Mr. Elmaliah stepped down as a member of the board and all committees of the board of directors of the Company.”
Oren Elmaliah was appointed as Chief Financial Officer at My Size, Inc..
“On March 6, 2025, the Company appointed Oren Elmaliah as the Company’s Chief Financial Officer, effective April 1, 2025 to replace Mr. Kles.”
Or Kles resigned as Chief Financial Officer at My Size, Inc..
“As previously disclosed, Or Kles, the Chief Financial Officer of My Size, Inc. (the “Company”) resigned effective March 31, 2025.”
Or Kles resigned as Chief Financial Officer at My Size, Inc..
“On January 14, 2025, Or Kles, Chief Financial Officer of My Size, Inc. (the “Company”), notified the Company of his decision to resign as the Company’s CFO, to be effective March 31, 2025.”
My Size, Inc. reported the three months ended March 31, 2024 results: revenue $2,984,000, net income $1,016,000.
“31, 2024. Key Financial Highlights for the Three Months Ended March 31, 2024 Compared to Prior Year Period and Recent Developments ● Consolidated revenue increased 314% to $2,984,000 primarily attributable to revenue generated following the acquisition of Orgad ● Software-as-a-Service (SaaS) revenues increased 25% to $177,000 ● Gross profit increased to”
My Size, Inc. entered into Inducement Letter with a certain holder (the "Holder") valued at aggregate gross proceeds of approximately $3.26 million (effective 2024-05-16).
“On May 16, 2024, My Size, Inc. (the “Company”) entered into an inducement offer letter agreement (the “Inducement Letter”) with a certain holder (the “Holder”) of certain of the Company’s existing warrants”
My Size, Inc.: Filed Certificate of Amendment to effect a 1-for-8 reverse stock split of common stock (effective 2024-04-19).
“the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment to its Certificate of Incorporation (the “Certificate of Amendment”) to effect the Reverse Stock Split, which will become effective as of 5:00 p.m. Eastern Time on April 19, 2024.”
My Size, Inc. shareholders approved Adjourn the Special Meeting to permit further solicitation if necessary at the 2024-04-15 meeting.
“Proposal 2. Approval of a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Reverse Stock Split Proposal: For Against Abstain Broker Non-Votes 1,856,595 587,730 4,283 0”
My Size, Inc. shareholders approved Grant discretionary authority to the Board to effect a reverse stock split within a range from 1-for-2 up to 1-for-15 at the 2024-04-15 meeting.
“Proposal 1. Grant discretionary authority to the Company’s Board to (A) amend the Amended and Restated Certificate of Incorporation of the Company to effect one or more consolidations of the issued and outstanding shares of the Company’s common stock pursuant to which the shares of common stock would be combined and reclassified into one (1) share of common stock at a ratio within the range from 1-for-2 up to 1-for-15 and (B) determine whether to arrange for the disposition of fractional interests by stockholders entitled thereto, to pay in cash the fair value of fractions of a share of common stock as of the time when those entitled to receive such fractions are determined, or to entitle stockholders to receive from the Company’s transfer agent, in lieu of any fractional share, the number of shares of common stock rounded up to the next whole number, provided that, (X) that we shall not effect Reverse Stock Splits that, in the aggregate, exceeds 1-for-5, and (Y) any Reverse Stock Spli”
My Size, Inc. shareholders approved Ratification of the appointment of Somekh Chaikin as the Company’s independent public accountant for the fiscal year ending December 31, 2023 at the 2023-12-27 meeting.
“Proposal 7. Ratification of the appointment of Somekh Chaikin as the Company’s independent public accountant for the fiscal year ending December 31, 2023: For Against Abstain Broker Non-Votes 1,600,836 17,005 2,000 0”
My Size, Inc. shareholders approved Authorization for issuance of shares underlying warrants in compliance with Nasdaq Listing Rule 5635(d) at the 2023-12-27 meeting.
“Proposal 6. Authorization, for the purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of shares of the Company’s common stock underlying certain warrants issued by the Company pursuant to that certain Inducement Letter, dated as of August 24, 2023, by and between the Company and the investor named on the signatory page thereto, and the Engagement Agreement between the Company and H.C. Wainwright & Co., LLC, dated as of August 24, 2023 in an amount equal to or in excess of 20% of the Company’s common stock outstanding immediately prior to the issuance of such warrants: For Against Abstain Broker Non-Votes 834,565 17,956 1,878 765,442”
My Size, Inc. shareholders approved Approval to delist the Company’s common stock from the Tel Aviv Stock Exchange at the 2023-12-27 meeting.
“Proposal 5. Approval to delist the Company’s common stock from the Tel Aviv Stock Exchange: For Against Abstain Broker Non-Votes 838,195 14,542 1,662 765,442”
My Size, Inc. shareholders approved Approval of an amendment to the My Size 2017 Equity Incentive Plan to increase the reservation of common stock for issuance thereunder to 1,040,000 shares from 289,000 shares at the 2023-12-27 meeting.
“Proposal 4. Approval of an amendment to the My Size 2017 Equity Incentive Plan to increase the reservation of common stock for issuance thereunder to 1,040,000 shares from 289,000 shares: For Against Abstain Broker Non-Votes 809,333 43,352 1,714 765,442”
My Size, Inc. shareholders approved An advisory vote on the frequency of future advisory votes on the compensation of the Company’s named executive officers at the 2023-12-27 meeting.
“Proposal 3. An advisory vote on the frequency of future advisory votes on the compensation of the Company’s named executive officers. Stockholders were given the choice of voting for future advisory votes on executive compensation to occur every one, two or three years: One Year Two Years Three Years Abstain 33,552 9,056 693,188 118,603”
My Size, Inc. shareholders approved An advisory vote on the compensation of the Company’s named executive officers at the 2023-12-27 meeting.
“Proposal 2. An advisory vote on the compensation of the Company’s named executive officers named in the Company’s proxy statement: For Against Abstain Broker Non-Votes 712,218 21,626 120,645 765,442”
My Size, Inc. shareholders approved Election of two Class II directors at the 2023-12-27 meeting.
“Proposal 1. Election of two Class II directors to serve on the Company’s Board for a term of three years or until their successors are elected and qualified: Nominee For Withheld Broker Non-Votes Oron Branitzky 835,955 18,544 765,442 Guy Zimmerman 840,379 14,020 765,442”
My Size, Inc. reported third quarter ended September 30, 2023 results: revenue $2,156,000. Guidance reaffirmed.
“Revenue for the three months ended September 30, 2023 increased 197% to $2,156,000 compared to $726,000 for the three months ended September 30, 2022.”
My Size, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
“November 3, 2023, My Size, Inc. (the “Company”) was notified (the “Notification Letter”) by the Nasdaq Listing Qualifications (“Nasdaq”) that it is not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days. Bas”
My Size, Inc. reported three months ended June 30, 2023 results: revenue $1,290,000, net income Net loss ... $1,291,000.
“the three months ended June 30, 2023. Key Financial Highlights for the Three Months Ended June 30, 2023 Compared to Prior Year Period ● Consolidated revenue increased 61% to $1,290,000 primarily driven by growth at Orgad and the acquisition of Naiz Fit ● Gross profit increased 61% to $519,000 ● Gross profit margin remained stable at 40% ● Cost of revenues”
My Size, Inc. reported the three months ended March 31, 2023 results: revenue $720,000, net income $2,654,000. Guidance reaffirmed.
“the three months ended March 31, 2023. Key Financial Highlights for the Three Months Ended March 31, 2023 Compared to Prior Year Period ● Consolidated revenue increased 78% to $720,000 primarily attributable to revenue generated following the acquisition of Orgad ● Software-as-a-Service (SaaS) revenues from MySizeID and Naiz Fit increased 223% to $142,000 ●”
My Size, Inc. reported the year ended December 31, 2022 results: revenue $4,459,000, net income $8,310,000. Guidance initiated.
“Key Financial Highlights for the Year Ended December 31, 2022 Compared to Prior Year Period ● Consolidated revenue increased 3304% to $4,459,000, primarily attributable to revenue generated following the acquisition of Orgad ● Software-as-a-Service (SaaS) revenues from MySizeID and Naiz Fit increased 150% to $327,000 ● Gross profit increased 384% to $634,000 ● Operating loss decreased 23% to $8,110,000 ● Net loss decreased 21% to $8,310,000 ● Cash balance at December 31, 2022 of $2.1 million, plus $3 million raised in January 2023”
My Size, Inc. entered into Engagement Agreement with H.C. Wainwright & Co., LLC (effective 2023-01-10).
“The Company also entered into a letter agreement (the “Engagement Agreement”) with H.C. Wainwright & Co., LLC (“Wainwright”)”
My Size, Inc. entered into Registration Rights Agreement (effective 2023-01-10).
“In connection with the PIPE Purchase Agreement, the Company entered into a registration rights agreement (the “Registration Rights Agreement”).”
My Size, Inc. entered into PIPE Purchase Agreement (effective 2023-01-10).
“In addition, the Company entered into a securities purchase agreement (the “PIPE Purchase Agreement,” and together with the RD Purchase Agreement, the “Purchase Agreements”)”
My Size, Inc. entered into RD Purchase Agreement (effective 2023-01-10).
“On January 10, 2023, My Size, Inc. (the “Company”) entered into a securities purchase agreement (the “RD Purchase Agreement”)”
My Size, Inc.: 提交了修订证书以实施1-for-25的反向股票拆分 (effective 2022-12-08).
“On December 7, 2022, the Board approved a 1-for-25 reverse stock split of the Company’s issued and outstanding shares of common stock (the “Reverse Stock Split”), and on the same day, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment to its Certificate of Incorporation (the “Certificate of Amendment”) to effect the Reverse Stock Split, which will become effective as of 5:00 p.m. Eastern Time on December 8, 2022.”
My Size, Inc. shareholders approved Adjournment of Annual Meeting to later date if necessary for further solicitation of proxies at the 2022-12-07 meeting.
“Proposal 5. Approval of a proposal to adjourn the Annual Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Reverse Stock Split Proposal;: For Against Abstain Broker Non-Votes 18,746,455 1,068,601 71,990 0”
My Size, Inc. shareholders approved Ratification of appointment of Somekh Chaikin as independent accountant for fiscal year 2022 at the 2022-12-07 meeting.
“Proposal 4. Ratification of the appointment of Somekh Chaikin as the Company’s independent public accountant for the fiscal year ending December 31, 2022: For Against Abstain Broker Non-Votes 19,204,804 621,914 60,328 0”
My Size, Inc. shareholders approved Amendment to 2017 Equity Incentive Plan to increase share reserve to 7,225,000 shares at the 2022-12-07 meeting.
“Proposal 3. Approval of an amendment to the My Size 2017 Equity Incentive Plan to increase the reservation of common stock for issuance thereunder to 7,225,000 shares from 5,700,000 shares: For Against Abstain Broker Non-Votes 13,208,736 1,298,094 9,504 5,370,712”
My Size, Inc. shareholders approved Grant discretionary authority to Board to effect reverse stock split within ratio 1-for-10 to 1-for-30 at the 2022-12-07 meeting.
“Proposal 2. Grant discretionary authority to the Company’s Board to (A) amend the Amended and Restated Certificate of Incorporation of the Company to effect one or more consolidations of the issued and outstanding shares of the Company’s common stock pursuant to which the shares of common stock would be combined and reclassified into one (1) share of common stock at a ratio within the range from 1-for-10 up to 1-for-30 and (B) determine whether to arrange for the disposition of fractional interests by stockholders entitled thereto, to pay in cash the fair value of fractions of a share of common stock as of the time when those entitled to receive such fractions are determined, or to entitle stockholders to receive from the Company’s transfer agent, in lieu of any fractional share, the number of shares of common stock rounded up to the next whole number, provided that, (X) that we shall not effect Reverse Stock Splits that, in the aggregate, exceeds 1-for-30, and (Y) any Reverse Stock Sp”
My Size, Inc. shareholders approved Election of two Class I directors at the 2022-12-07 meeting.
“Proposal 1. Election of two Class I directors to serve on the Company’s Board for a term of three years or until their successors are elected and qualified: Nominee For Withheld Broker Non-Votes Arik Kaufman 13,690,324 826,010 5,370,712 Oren Elmaliah 13,737,737 778,597 5,370,712”
Ezequiel Javier Brandwain was appointed as Chief Commercial Officer at My Size, Inc..
“On January 30, 2022, My Size, Inc. (the “Company”), appointed Ezequiel Javier Brandwain to serve as the Company’s Chief Commercial Officer, effective as of February 1, 2022.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.